Connecting Clinical Trials to RWD
Clinical trials remain the gold standard of medical evidence generation, yet the data historically collected in trials provides only a slice of a participant’s health journey. This panel looks at models and use cases associated with using real-world data in a clinical trial setting.
Speakers included:
- Najat Khan, Chief Data Science Officer and Global Head, Strategy and Operations, Janssen Research & Development, LLC
- Jamie Macdonald, CEO, Parexel
- Jill Pellegrino, VP Recruitment and RWE, CVS Trials, CVS Health
- Andrew von Eschenbach, Former Commissioner, FDA
This panel was moderated by Jo Natauri, Partner, Global Head of Healthcare Private Investing, Goldman Sachs.